Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice

scientific article published on 20 February 2007

Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPENDO.00303.2006
P8608Fatcat IDrelease_ilxl754pgvemza5tjdmyrn4nf4
P698PubMed publication ID17311896
P5875ResearchGate publication ID6493631

P50authorBo AhrénQ5544506
Karl ThomasethQ46865302
P2093author name stringPacini G
Pavan A
P2860cites workTissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequencesQ28306665
Insulin transport across capillaries is rate limiting for insulin action in dogsQ34579532
Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approachQ38723548
Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.Q40925170
Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in miceQ43733884
Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.Q43813981
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteersQ43913912
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group studyQ43919658
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanismQ45176382
Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in miceQ46678800
A new dynamic index of insulin sensitivityQ46987713
Multidisciplinary modelling of biomedical systems.Q52014564
Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.Q52659557
Mixed-Effects Models in Sand S-PLUSQ58040120
GLP-1 does not acutely affect insulin sensitivity in healthy manQ58449053
P433issue6
P921main subjectpreproinsulinQ7240673
P304page(s)E1808-14
P577publication date2007-02-20
P1433published inAmerican Journal of Physiology - Endocrinology and MetabolismQ15765671
P1476titleGlucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice
P478volume292

Reverse relations

cites work (P2860)
Q35801801Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice
Q33800196Glucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice
Q41564006Methods and models for metabolic assessment in mice

Search more.